0001104659-22-065250.txt : 20220526 0001104659-22-065250.hdr.sgml : 20220526 20220526160535 ACCESSION NUMBER: 0001104659-22-065250 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220525 FILED AS OF DATE: 20220526 DATE AS OF CHANGE: 20220526 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FLESHNER NEIL E. CENTRAL INDEX KEY: 0001868209 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39373 FILM NUMBER: 22969931 MAIL ADDRESS: STREET 1: 4850 WEST 78TH STREET CITY: INDIANAPOLIS STATE: IN ZIP: 46268 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: POINT Biopharma Global Inc. CENTRAL INDEX KEY: 0001811764 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 850800493 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4850 WEST 78TH STREET CITY: INDIANAPOLIS STATE: IN ZIP: 46268 BUSINESS PHONE: (317) 543-9957 MAIL ADDRESS: STREET 1: 4850 WEST 78TH STREET CITY: INDIANAPOLIS STATE: IN ZIP: 46268 FORMER COMPANY: FORMER CONFORMED NAME: Therapeutics Acquisition Corp. DATE OF NAME CHANGE: 20200511 4 1 tm2217064d1_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2022-05-25 0 0001811764 POINT Biopharma Global Inc. PNT 0001868209 FLESHNER NEIL E. 4850 WEST 78TH STREET INDIANAPOLIS IN 46268 1 1 0 0 Chief Medical Officer Common Stock 2022-05-25 4 S 0 564204 7.51 D 3023045 D Common Stock 233171 I 1510789 Ontario Inc. Common Stock 358 I Trust Controlled by Wife The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.50 to $7.75, inclusive. The reporting person undertakes to provide to POINT Biopharma Global Inc., any security holder of POINT Biopharma Global Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. A corporation controlled by Reporting Person. A trust, whose trustee is the Reporting Person's spouse. /s/ William L. Demers, by Power of Attorney for Neil E. Fleshner 2022-05-26